"From more common digestive tract diagnoses such as heartburn and colorectal disease to complex diagnoses for liver cancer and pancreatic cancer, Mercy Medical Center and The Institute for Digestive Health & Liver Disease offer patients a comprehensive and coordinated approach, aiming to continue to be one of the best Gastroenterology Centers in Baltimore and the Mid-Atlantic region. The dedicated physician team works to provide the best treatment options available for digestive disorders. The Center's top specialists provide advanced therapies, education and surgical treatment options that are ranked among the best available in the United States. Academic and research leadership drives our doctors to actively participate in research and c"

During the past decade, Institute for Digestive Health and Liver Disease conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institute for Digestive Health and Liver Disease" are "Crohn's Disease" (2 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Institute for Digestive Health and Liver Disease" in a lesser frequency.

Most popular intervention types in "Institute for Digestive Health and Liver Disease" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Guselkumab" (2 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Digestive Health and Liver Disease" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Institute for Digestive Health and Liver Disease". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institute for Digestive Health and Liver Disease, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Digestive Health and Liver Disease, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".